ASTHMANEFRIN
Live / Registered — Registered and renewed (as of 21 Apr 2022)
What this means for you
Registered since 30 Oct 2012. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 30 Oct 2022).
Record
- Serial number
- 85518098
- Registration number
- 4235335
- Mark type
- Stylized text
- Filed
- 17 Jan 2012
- Published for opposition
- 12 Jun 2012
- Registered
- 30 Oct 2012
- Next maintenance due
- 30 Oct 2022
- Attorney of record
- E. Eric Mills
Goods and services
- Class 005 — Pharmaceuticals: Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders
Owner
- Nephron Pharmaceuticals Corporation, West Columbia, SC, US
- Nephron Pharmaceuticals Corporation, Orlando, FL, US
- Nephron Pharmaceuticals Corporation, Orlando, FL, US
Prosecution history
- 22 Jan 2025 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 16 May 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 16 May 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 16 May 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 21 Apr 2022 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 21 Apr 2022 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 21 Apr 2022 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 18 Apr 2022 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 05 Apr 2022 — POST REGISTRATION ACTION MAILED - SEC. 8 & 9
- 05 Apr 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 06 Dec 2021 — TEAS SECTION 8 & 9 RECEIVED
- 30 Oct 2021 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 16 Feb 2018 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 16 Feb 2018 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 02 Feb 2018 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED